Wound treatment composition

2:

• The method according to claim 1, wherein the wound is a skin wound and the method comprises:
• applying the composition to the skin wound of the subject.

3:

• The method according to claim 2, wherein the skin wound is a pressure ulcer, a skin ulcer, a burn, a laceration, an abrasion, a leg ulcer, a diabetic ulcer, a venous stasis ulcer, an ischemic (arterial) ulcer, a foot ulcer, a foot gangrene, or a radiation skin ulcer.

4:

• The method according to claim 2, wherein the skin wound is a pressure ulcer.

5:

• The method according to claim 1, wherein the composition is for promotion of epidermis formation.

6:

• The method according to claim 1, wherein the composition acts via a fibroblast.

7:

• The method according to claim 1, wherein the wound is a mucosal wound, and the method comprises:
• applying the composition to the mucosal wound of the subject.

8:

• The composition according to claim 7, wherein the mucosal wound is an oral mucosal wound or an ocular mucosal wound.

9:

• The method according to claim 8, wherein
• the mucosal wound is an oral mucosal wound, and
• the oral mucosal wound is an oral mucositis, a stomatitis, an oral ulcer, an oral erosion, a glossitis, or a cheilitis.

10:

• The method according to claim 8, wherein
• the mucosal wound is an ocular mucosal wound, and
• the ocular mucosal wound is a keratoconjunctival epithelial disorder, a corneal epithelial disorder, a corneal erosion, superficial punctate keratopathy, dry eye, a keratitis accompanied by a corneal wound, or conjunctivitis accompanied by a conjunctival wound.

11:

• The method according to claim 8, wherein
• the mucosal wound is an ocular mucosal wound, and
• the ocular mucosal wound is dry eye accompanied by a keratoconjunctival epithelial disorder.

12:

• The method according to claim 1, wherein the composition is a preparation for external use.

13:

• The method according to claim 12, wherein the preparation for external use is an ointment or a cream, and the method comprises:
• applying the composition to a skin wound of the subject.

14:

• The method according to claim 12, wherein the preparation for external use is an eye drop or an eye ointment, and the method comprises:
• applying the composition to an eye of the subject.

15:

• The method according to claim 12, wherein the preparation for external use is a mouthwash, an oral spray, or an oral ointment, and the method comprises:
• applying the composition to an oral cavity of the subject.

16:

• The method according to claim 12, wherein the preparation for external use contains N-({2-[4-(difluoromethoxy)-3-(propan-2-yloxy)phenyl]-1,3-oxazol-4-yl}methyl)-2-ethoxybenzamide or its salt in an amount of 0.1 to 10 mass % in terms of N-({2-[4-(difluoromethoxy)-3-(propan-2-yloxy)phenyl]-1,3-oxazol-4-yl}methyl)-2-ethoxybenzamide.

17:

• The method according to claim 12, wherein the method comprises:
• administering the composition 1 to 2 times a day.

18:

• The method according to claim 12, wherein the method comprises:
• administering the composition 1 to 4 times a day.

19:

• The method according to claim 1, wherein the composition is a wound dressing.